Reps. Paulsen, Kind defend device tax repeal

MassDevice.com coverage of the medical device tax

A bipartisan duo of U.S. Representatives criticized the editorial board of the Washington Post this week over an editorial that called the Senate’s recent non-binding vote to repeal the medical device tax a "budget-busting mistake."

The editorial, published on March 22, depicted the device tax as the medical device industry’s reasonable share of a healthcare reform measure that would bring health insurance to 27 million people, a measure that’s projected to cost about $1.2 trillion over 10 years.

"Asking the medical device industry to chip in 2.5% of that doesn’t seem unreasonable, given the $100 billion-plus sector’s profitability – which is bolstered by federal programs such as Medicare and Medicaid," the editors wrote.

Last Thursday, the Senate voted 79-20 in favor of a bipartisan amendment to repeal the medical device tax. The non-binding measure, proposed by Sens. Amy Klobuchar (D-Minn.) and Orrin Hatch (R-Utah), was part of the Senate’s continuing budget resolution.

The article briefly targeted several of the tax repeal opposition’s primary arguments, particularly that the levy, which is expected to generate about $30 billion in federal revenue over 10 years, will result in more than 40,000 lost U.S. jobs and that it will incentivize companies to ship those jobs overseas. The editors called those arguments a "doomsday scenario" which "falls apart on closer inspection."

The medical device tax contains no inherent incentives to ship jobs overseas because it taxes all devices sold in the U.S., including imports, the editors noted.

And although the 27 million newly insured people skew mostly from a younger demographic and are unlikely to be comprised highly of the older patients who are the prime customers of the medical device industry, "their additional device usage won’t be zero," according to the Washington Post editors.

More medical device tax coverage from MassDevice.com.

Those arguments missed the point of the repeal efforts, according to Reps. Erik Paulsen (R-Minn.) and Ron Kind (D-Wisc.), who responded to the editorial this week with a letter to the editor.

They countered the "windfall" rhetoric that medical device makers will reap a benefit from the newly insured patients, citing Massachusetts as a state where expanded insurance access didn’t bump revenue for the medical device industry, which has a heavy presence in the Bay State.

The Reps. further justified medical device tax repeal as a means of protecting an important U.S. industry, one which is facing ever-increasing competition on the global market.

"It is crucial that we enhance our strengths and export American ingenuity," Paulsen and Kind wrote. "Repealing the medical-device tax will allow today’s entrepreneurs – whether working in a university lab or their bedrooms – to become tomorrow’s visionaries."

RSS From Medical Design & Outsourcing

  • Teknor Apex to showcase wide range of PVC compounds for medical devices at Medtec China
    Building on its international leadership role as a supplier of medical-grade PVC compounds, Teknor Apex Company has developed flexible and rigid formulations that address the special needs of device manufacturers. The company will highlight these capabilities at Medtec China 2015. “Teknor Apex produces or markets medical-grade PVC compounds in China, Singapore, Europe, and the United […]
  • The Raspberry Pi eco-system goes interstellar with the new Raspberry Pi Sense HAT
    Newark element14 has globally launched the latest addition to the expanding ecosystem of Raspberry Pi accessories, the Raspberry Pi Sense HAT, as featured in the ‘Astro Pi’ space mission. The Sense HAT will enable enthusiasts to control the same hardware used in space. The Sense HAT attaches to the Raspberry Pi board, and can be […]
  • CommScope completes acquisition of TE Connectivity’s Telecom
    CommScope Holding Company, has completed its previously announced acquisition of TE Connectivity’s Telecom, Enterprise and Wireless businesses, a leader in fiber optic connectivity for wireline and wireless networks. The all-cash transaction, valued at approximately $3 billion, strengthens CommScope’s position as a leading communications infrastructure provider with deeper resources to meet the world’s growing demand for network […]
  • SPI awards IKO Prosthetic Creative System the Student Design International Design Excellence Award
    SPI: The Plastics Industry Trade Association congratulated IKO Prosthetic Creative System for winning the SPI Student Design Award, part of the Industrial Designers Society of America’s (IDSA’s) International Design Excellence Awards (IDEA) program. The award was presented to IKO, an innovative, youth-focused prosthetic design company led by Chicago-based designer Carlos Torres, by SPI’s Senior Director of […]
  • New assay could revolutionize diagnosis and treatment of life-threatening disease
    Invasive Fungal Disease (IFD) is an emerging global health problem associated with high mortality rates in severely immunocompromised patients, such as those undergoing intensive chemotherapy or stem cell transplantation, and in patients suffering immune compromising conditions such as AIDS. The most common causative agents of this disease have been identified as Candida and Aspergillus species, […]
  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]

Leave a Reply